RDY
Dr. Reddy’s Laboratories Ltd
12.30$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -73.6% | -97.1% | +6,138.2% | +9.7% | -28.9% | +232.3% | -33.5% | +6.5% | -30.0% | +41.5% | -106.0% | – | |
| – | -0.5% | -98.8% | +8,422.9% | +4.3% | +18.7% | -3.5% | +4.6% | +6.0% | +3.2% | +8.6% | -5.1% | – | |
| – | -3.9% | -2.0% | +4.1% | +5.9% | -3.7% | +9.7% | -0.9% | -10.7% | -80.0% | +370.0% | +3.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -554.4% | – | – | – | – | – | -1,502.6% | – | – | – | -254.2% | – | |
| – | +28.0% | -98.7% | +10,050.4% | +23.1% | +11.5% | +27.5% | -9.8% | -0.1% | -27.8% | -35.9% | -21.0% | – | |
| – | – | – | +14,148.0% | -5.8% | -71.4% | +143.7% | +44.3% | -50.3% | +7.8% | +174.2% | – | – | |
| – | -100.0% | – | -100.0% | – | -100.0% | – | -100.0% | – | -98.3% | -63.5% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -90.8% | -438.3% | -95.0% | – | +267.0% | -5.6% | -171.0% | – | |
| – | – | -100.0% | +560,328.6% | +69.3% | -96.3% | -1,349.2% | -83.7% | +342.5% | – | +12.4% | -181.4% | – | |
| – | -195.1% | – | – | – | -72.6% | -10.6% | -458.0% | – | +870.2% | -148.4% | – | – | |
| – | -102.2% | – | +2,742.1% | -32.1% | -256.3% | – | -58.3% | +21.3% | -34.0% | +199.6% | -143.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.